Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
Renato de Filippis,1 Raffaele Gaetano,1 Georgios Schoretsanitis,2 Giuseppe Verde,1 Cesare Anthony Oliveti,3 John M Kane,2,4,5 Cristina Segura-Garcia,6 Pasquale De Fazio1 1Psychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy; 2The Zucker Hillside Hos...
Saved in:
Main Authors: | de Filippis R, Gaetano R, Schoretsanitis G, Verde G, Oliveti CA, Kane JM, Segura-Garcia C, De Fazio P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/036e476c5c7d4bd89f34c75873edfdb2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
by: Fitri Fareez Ramli, et al.
Published: (2021) -
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
by: Amina Aissa, et al.
Published: (2022) -
Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
by: Cheng MF, et al.
Published: (2016) -
Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
by: Li Y, et al.
Published: (2017) -
A case of schizophrenia comorbid for tetralogy of Fallot treated with clozapine: further considerations on a role for 22q.11.2 in the proneness for seizures
by: Kashiwagi H, et al.
Published: (2017)